AHA GUIDELINES Bundle (free trial)

Lower Extremity Peripheral Artery Disease 2024

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1521560

Contents of this Issue

Navigation

Page 44 of 55

45 10.3.1. Pressure Offloading for CLTI COR LOE Recommendations 1 A 1. Patients with CLTI and diabetic foot ulcers should receive pressure offloading, when possible, to promote tissue growth and wound healing. 1 B-R 2. Patients with PAD and previous diabetic foot ulcers should be referred for customized footwear that accommodates, protects, and fits the shape of their feet. 2b C-EO 3. Patients with CLTI and foot ulcers who do not have diabetes may be considered for pressure offloading to promote tissue growth and wound healing. 10.3.2. Wound Care and Management of Infection for CLTI COR LOE Recommendations 1 B-NR 1. In patients with CLTI, prompt management of foot infection with antibiotics, debridement, and other surgical management is recommended. 1 C-LD 2. In patients with CLTI with nonhealing wounds, wound care should be provided to optimize the wound-healing environment after revascularization with the goal of complete wound healing. 2b B-NR 3. In patients with CLTI with nonhealing diabetic foot ulcers, hyperbaric oxygen therapy may be considered to assist in wound healing after revascularization. 10.3. Minimizing Tissue Loss for CLTI Table 17. Components of Wound Care for Patients With CLTI • Revascularization for adequate perfusion (see Section 10.2, "Revascularization for CLTI") • Debridement of nonviable tissue • Management of infection, inflammation, or both • Pressure offloading, when appropriate (see Section 10.3.1, "Pressure Offloading for CLTI") • Maintaining conducive wound-healing environment (ie, local wound care, dressings) (see Section 10.3.2, "Wound Care and Management of Infection for CLTI") • Pain control • Medical optimization of host factors (eg, smoking cessation, glycemic control) (see Section 5, "Medical Therapy and Preventive Footcare for Patients with PAD") • Optimization of tissue growth • Control of edema Modified with permission from Gerhard-Herman MD, et al. Copyright © 2017 American Heart Association, Inc., and American College of Cardiolog y Foundation.

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Lower Extremity Peripheral Artery Disease 2024